Biocon, an Asia-based biotech, has opened the doors of its Integrated Research and Development Centre, Biocon Research Centre (BRC) in India, aimed at pursuing world class research on biologics that will address unmet medical needs.

As a center with multi-disciplinary capabilities in molecular biology, biologics process sciences, formulation research and preclinical and clinical development, BRC is a first-of-its-kind facility in South-East Asia. The center is also equipped with cutting edge instrumentation for extensive molecular and functional characterization of biologics.

Noble Laureate professor Kurt Wuthrich inaugurated the center. "I am quite enthralled with the Biocon Research Centre's capability which is [on] par with international standards. I will keenly watch the outcome of innovation from this center as I see a lot of promise in the scientific talent at Biocon,” he said.

The 200,000 square foot center will house a molecular biology lab, several biologics process science labs, a formulations development lab, a molecular characterization lab, a functional bioassay lab, and preclinical and clinical development groups. Biocon dedicated one of the research wings in honor of scientific leader C.N.R.Rao, which was also unveiled during the inauguration.

A team of over 300 scientists based at the center will be engaged in cutting edge biologics research. Biocon aims to attract outstanding scientists from the best institutes around the world and engage with international thought leaders, as well as participate in technical programs as an effective way to enable innovation through knowledge sharing. An independent quality group at BRC will ensure compliance to Good Laboratory Practices and International regulatory guidelines for developing 'best in class' biologics and biosimilars.

Abhijit Barve, president of R&D, Biocon, said, "This world class facility in India is a dream come true for any scientist and demonstrates Biocon's commitment to world class research. This will allow cross pollination of ideas across groups that will breed a new culture of innovation and enable us to deliver on our vision."